Yield Growth: Beyond Cannabis Flower & Edibles
January 24th, 2019
Exclusive, News, Top News
Most investors are familiar with cannabis flower, edibles, and extracts, which have created overnight multi-billion dollar markets around the world. With rising competition in many of these markets, investors may want to turn their attention to lesser known subsets of the cannabis industry, including medical cannabis research and the multi-trillion dollar health and wellness industry that’s ripe for innovative new products.
The Yield Growth Corp.(CSE: BOSS) manufactures and distributes cannabis-infused wellness products under its Urban Juve and UJ Topicals brands, inspired by the ancient healing powers of Ayurvedic medicine. Over the past several quarters, the company has expanded beyond Canada and into the United States and Europe with a focus on wellness. Investors may want to keep an eye on the company as it continues its expansion into the new year.
Cannabis Wellness Space
Health and wellness products are constantly evolving with hot new ingredients, from probiotics to fight inflammation to caviar to stimulate collagen production. Some of these ingredients produce noticeable effects, but most of them are simply packaged up and marketed well enough to generate buzz. Hemp oil has already made its way into the market but cannabis-infused wellness products are only starting to appear.
The same cannabinoids that are consumed to get a ‘high’ bind to different receptors on the skin when applied as a beauty product. Cannabinoids are rich in fatty acids and can help with hydration, while some studies have shown that they can be anti-inflammatory and help reduce sebaceous gland activity. They could help with a wide range of dermatological issues, such as eczema, dandruff, psoriasis, dull skin, and even acne.
The health and wellness industry is worth more than $4 trillion per year on a global level, while the beauty subset is worth over $120 billion per year. While some of the cannabis-infused products can only be sold in a few states where cannabinoids have been legalized, the Farm Bill helped pave the way for the hemp-based CBD products to be widely distributed throughout the United States and around the world.
Innovative Product Portfolio
Yield Growth’s wholly-owned Urban Juve subsidiary has developed more than 50 wellness products, including anti-aging serums, bath salts, pain patches, and antihistamines. While most companies rely on hemp seed oil, the company sets itself apart with hemp root oil and its anti-inflammatory properties. The company has more than ten patents pending on extraction processes for hemp root oil, which could create a significant barrier to entry.
The company’s wholly-owned UJ Topicals subsidiary develops THC and CBD infused topicals with distribution agreements in place to 400 stores throughout Oregon. In addition, the business has an Oregon Liquor Control Commission (OLCC) approved license to manufacture and distribute cannabis products in Oregon. These products are popular for localized pain relief, muscle soreness, tension and inflammation.
These products are being developed and marketed by a strong management team with experience at PepsiCo (PEP), Coca-Cola (KO), Skechers USA (SKX), Aritzia LP (ATZ), M.A.C Cosmetics, and other multinational companies. CEO Penny Green co-founded Merus Labs (TSX: MSL), which was sold in July 2017 for $342 million and co-founded Glance Technologies (CSE: GET), which achieved a $480 million market capitalization.
The Yield Growth Corp.(CSE: BOSS) is well positioned to capitalize on the cannabis health and wellness space with more than 50 products on the market and many more product lines on the way. With the recent interest in cannabis beverage companies, it’s possible that major skincare brands will start to make acquisitions in the cannabis wellness space, where the company aims to become a well-defined leader.
For more information, visit the company’s website at www.yieldgrowth.com.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.